EMILY REVENSON: Open Payments
NPI 1508026089 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,577 in 112 payments from 24 companies in 2025. Trend: 2023 $2,429 · 2024 $3,227 · 2025 $2,577
Food & beverage: $2,427Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 11 | $575 |
| GlaxoSmithKline, LLC. | 23 | $321 |
| AstraZeneca Pharmaceuticals LP | 13 | $274 |
| HARMONY BIOSCIENCES LLC | 7 | $159 |
| Avadel CNS Pharmaceuticals, LLC | 6 | $143 |
| Merck Sharp & Dohme LLC | 5 | $138 |
| GENZYME CORPORATION | 6 | $120 |
| Regeneron Healthcare Solutions, Inc. | 6 | $107 |
| Axsome Therapeutics, Inc. | 5 | $103 |
| PFIZER INC. | 4 | $81 |
Products named: XYWAV, DUPIXENT, NUCALA, TEZSPIRE, WAKIX, LUMRYZ, WINREVAIR, Sunosi.
Industry payments across VA — which companies pay providers there.
